Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
09/19/1995 | US5451408 Pain management with liposome-encapsulated analgesic drugs |
09/19/1995 | US5451407 Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug |
09/19/1995 | US5451393 Wet grinding a contrast agent, modifying surface and separation |
09/19/1995 | CA1337038C Device comprising means for protecting and dispensing fluid sensitive medicament |
09/16/1995 | CA2144591A1 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen |
09/16/1995 | CA2144556A1 Alpha-pyrones compositions used for inducing and activating the growth of hair and (or) slowing down the loss of hair; use thereof |
09/15/1995 | CA2144500A1 Pharmaceutical preparation |
09/14/1995 | WO1995024736A1 High vertical aspect ratio thin film structures |
09/14/1995 | WO1995024489A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
09/14/1995 | WO1995024485A2 Coordinate in vivo gene expression |
09/14/1995 | WO1995024472A1 Microfabricated capsules for isolation of cell transplants |
09/14/1995 | WO1995024430A2 Block and graft copolymers and methods relating thereto |
09/14/1995 | WO1995024219A1 Veterinary formulation |
09/14/1995 | WO1995024201A1 Liposome preparation |
09/14/1995 | WO1995024197A1 Percutaneously absorbable plaster comprising acid-addition salt of morphine |
09/14/1995 | WO1995024188A1 Slow-release tablet containing diclofenac-na |
09/14/1995 | WO1995024187A1 Plaster-shaped transdermal system with a tamoxifen derivative |
09/14/1995 | WO1995024184A1 Gas filled microspheres as magnetic resonance imaging contrast agents |
09/14/1995 | WO1995024183A1 Methods and compositions for pulmonary delivery of insulin |
09/14/1995 | WO1995024179A1 LOW pH, HYDROLYTICALLY STABLE, COSMETIC COMPOSITIONS CONTAINING ACIDIC ACTIVES |
09/14/1995 | WO1995024172A1 Drug-containing adhesive composite transdermal delivery device |
09/14/1995 | WO1995024168A1 In situ dissolution of alginate coatings of biological tissue transplants |
09/14/1995 | DE4408326A1 Retardtablette mit einem Gehalt an Diclofenac-Na Release tablet containing diclofenac-Na |
09/14/1995 | DE4408104A1 Magnesium stearate dispersion in alcohol |
09/14/1995 | CA2185231A1 Low ph, hydrolytically stable, cosmetic compositions containing acidic actives |
09/14/1995 | CA2185227A1 Percutaneous absorption applying sheet comprising acid salt of morphine |
09/14/1995 | CA2185117A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
09/14/1995 | CA2185016A1 Transdermal system in the form of a patch comprising a tamoxifen derivative |
09/14/1995 | CA2184994A1 Veterinary formulation |
09/14/1995 | CA2184834A1 Liposome preparation |
09/14/1995 | CA2184814A1 Block and graft copolymers and methods relating thereto |
09/14/1995 | CA2179287A1 In situ dissolution of alginate coatings of biological tissue transplants |
09/13/1995 | EP0671176A1 Percutaneously absorbable preparation |
09/13/1995 | EP0671175A2 Sustained release compositions for treating periodontal disease |
09/13/1995 | EP0671174A2 Formulation for increasing the weight of livestock, comprising an ionophore and selenium |
09/13/1995 | EP0671169A1 Nanoparticles containing an active agent and a cetal-tartanic acid amides polymer, process for preparation thereof and their use |
09/13/1995 | EP0671168A1 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract |
09/13/1995 | EP0671167A1 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract |
09/13/1995 | EP0671166A2 Nutrient-supplying preparation |
09/13/1995 | EP0671165A2 Collagen-based injectable drug delivery system and its use |
09/13/1995 | EP0671164A1 Skin whitening and/or anti aging composition and uses thereof |
09/13/1995 | EP0671162A2 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
09/13/1995 | EP0671156A1 Cosmetic or pharmaceutical compositions containing liposomes |
09/13/1995 | EP0670738A1 Methods for enhancing vascularization of implant devices |
09/13/1995 | EP0670725A1 Pharmaceutical compositions for use in gastrointestinal washes |
09/13/1995 | EP0670722A1 Cimetidine granules coated with a partially hydrogenated vegetable oil |
09/13/1995 | EP0670718A1 Pulsatile particles drug delivery system |
09/13/1995 | EP0670717A1 Supported liquid membrane delivery devices |
09/13/1995 | EP0670716A1 Tastemasked pharmaceutical materials |
09/13/1995 | EP0670715A1 Oral delivery composition forming a microemulsion. |
09/13/1995 | EP0670714A1 Retinoic acid-containing compositions |
09/13/1995 | EP0670713A1 A pharmaceutical formulation |
09/13/1995 | EP0644746A4 The use of glycerin in moderating transdermal drug delivery. |
09/13/1995 | EP0615440B1 Medicament containing a 2-arylpropionic acid derivate as a nanosol and its preparation |
09/13/1995 | EP0563094B1 Pharmaceutical compositions |
09/13/1995 | EP0525167B1 Sustained drug release through topical application of bioadhesive liposomes |
09/13/1995 | EP0451236B1 Process for making aqueous dispersions |
09/13/1995 | CN1108137A Pharmaceutical compositions |
09/13/1995 | CN1108122A Medicinal prepn. for treating scald and its prepn. method |
09/13/1995 | CN1108119A Traditional Chinese medicinal extract containing Agkistrodon acutus |
09/13/1995 | CN1108108A Medical prepn. for curing diabetes and its prepn. method |
09/13/1995 | CN1108089A Cosmetic or skin using composition of emulsion of oil covered with water formed with oil drops and covered with liquid |
09/12/1995 | US5449679 Process and products for reducing biological fluid levels of a lipid soluble waste |
09/12/1995 | US5449670 Composition and method for the transdermal delivery of bioactive peptides |
09/12/1995 | US5449664 Nucleosides |
09/12/1995 | US5449521 Supported drugs with increased dissolution rate, and a process for their preparation |
09/12/1995 | US5449520 Pharmaceutical composition for rectal administration of active principles exhibiting a prevalently topical medication action at the colon level |
09/12/1995 | US5449513 Physical trapping type polymeric micelle drug preparation |
09/12/1995 | CA2064765C Biphasic transdermal drug delivery device |
09/12/1995 | CA2039197C Pharmaceutic formulation for the treatment of alcoholism |
09/12/1995 | CA1336961C Long lasting composition of propafenone and quinidine for treatment of cardiac conditions |
09/12/1995 | CA1336958C Peroral preparation of acid-unstable compound |
09/12/1995 | CA1336957C Phospholipid-containing composition, a process for its preparation and its use as an excipient for pharmaceutical substances |
09/10/1995 | CA2144216A1 Nanoparticles containing an active substance and a ketalized polytartramidic acid, process for their preparation, and use thereof |
09/08/1995 | WO1995023867A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
09/08/1995 | WO1995023862A1 Animals with targeted gene disruption |
09/08/1995 | WO1995023854A1 IMPROVED DNase LIQUID SOLUTIONS |
09/08/1995 | WO1995023615A1 Gas-containing microcapsules useful as contrast agents for diagnostic imaging |
09/08/1995 | WO1995023613A1 PHARMACEUTICALLY ACCEPTABLE DNase FORMULATION |
09/08/1995 | WO1995023602A1 Antitussive composition containing an antitussive and benzydamine |
09/08/1995 | WO1995023601A1 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient |
09/08/1995 | WO1995023600A1 Sublingual or buccal pharmaceutical composition |
09/08/1995 | WO1995023598A1 Controlled release microporous membranes |
09/08/1995 | WO1995023597A1 Systemic drug delivery system through application on nails |
09/08/1995 | WO1995023596A1 Adhesive free topical pharmaceutical formulations |
09/08/1995 | WO1995023595A1 Concentrated acetaminophen solution compositions |
09/08/1995 | WO1995023594A1 Granular product or tablet containing an effervescent system and an active pharmaceutical substance, as well as a method for its preparation |
09/08/1995 | WO1995023593A1 Controlled release oxybutynin formulations |
09/08/1995 | WO1995023592A1 Liposome compositions and methods for the treatment of atherosclerosis |
09/08/1995 | WO1995023591A1 Oral vehicle compositions |
09/08/1995 | WO1995023590A1 Anthelmintic preparation |
09/08/1995 | WO1995023589A1 Clear non-alcoholic sinus and allergy medication |
09/08/1995 | WO1995023586A2 Cosmetic and/or pharmaceutical preparations |
09/08/1995 | CA2184707A1 Animals with targeted gene disruption |
09/08/1995 | CA2184113A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
09/08/1995 | CA2184075A1 Systemic drug delivery system through application on nails |
09/08/1995 | CA2179892A1 Anthelmintic preparation |
09/07/1995 | DE4407015A1 Kosmetische und/oder pharmazeutische Zubereitungen Cosmetic and / or pharmaceutical preparations |
09/06/1995 | EP0670326A2 Crystalline maltosyl glucoside, and its production and use |
09/06/1995 | EP0670166A2 Formulations for orally administered pharmaceutical agents |